Optimal control of a delayed hepatitis B viral infection model with HBV DNA‐containing capsids and CTL immune response

DOI10.1002/OCA.2407zbMath1398.49045OpenAlexW2782837235MaRDI QIDQ4585054

Jaouad Danane, Karam Allali, Adil Meskaf

Publication date: 6 September 2018

Published in: Optimal Control Applications and Methods (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1002/oca.2407

zbMATH Keywords

optimal control numerical simulation HBV infection CTL response

Mathematics Subject Classification ID

Medical applications (general) (92C50) Existence theories for optimal control problems involving ordinary differential equations (49J15) Discrete approximations in optimal control (49M25) Optimality conditions for problems involving ordinary differential equations (49K15) Variational principles of physics (49S05)

Related Items (13)

Mathematical analysis and optimal control of giving up the smoking model ⋮ Global dynamics of a general diffusive HBV infection model with capsids and adaptive immune response ⋮ Optimal control of combined antiretroviral therapies in an HIV infection model with cure rate and fusion effect ⋮ Mathematical analysis of hepatitis B epidemic model with optimal control ⋮ Dynamics on Hepatitis B Virus Infection In Vivo with Interval Delay ⋮ Mathematical Modeling of HBV Infection with DNA-Containing Capsids and Therapy ⋮ Dynamical analysis and optimal control for a delayed viral infection model ⋮ A delayed diffusive HBV model with nonlinear incidence and CTL immune response ⋮ Optimal Control of a Delayed Hepatitis B Viral Infection Model with DNA-Containing Capsids and Cure Rate ⋮ Optimal Control of an HIV Infection Model with Logistic Growth, CTL Immune Response and Infected Cells in Eclipse Phase ⋮ Optimal control of viral infection model with saturated infection rate ⋮ Dynamics and control strategy for a delayed viral infection model ⋮ An optimal control strategy for antiretroviral treatment of HIV infection in presence of immunotherapy

This page was built for publication: Optimal control of a delayed hepatitis B viral infection model with HBV DNA‐containing capsids and CTL immune response